Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Sales/Maturities of Investments

$20.46M

TTM · Period ending: · USD

LCTX logo

LCTX Sales/Maturities of Investments

Latest reported$20.46M
LCTX TTM Sales/Maturities of Investments ($0.00 → $20.46M)
High-resolution chart · PNG

LCTX sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000,000
3,000,000
3,000,000
3,000,000
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.